Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Great Tree Pharmacy CoROCO:6469 +0.86%69 5-Year Yield-on-Cost % is 58.10 as of Aug. 10, 2026, which is 226% above its 10-year median of 17.82. GuruFocus rates ROCO:6469 with a GF Score™ of 69/100 and a GF Value™ of NT$168.07 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 275 Healthcare Providers & Services companies, Great Tree Pharmacy Co ranks better than 98.91% on this metric.
Great Tree Pharmacy Co's yield on cost for the quarter that ended in Mar. 2026 was 58.10.
The historical rank and industry rank for Great Tree Pharmacy Co's 5-Year Yield-on-Cost % or its related term are showing as below:
ROCO:6469'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 2.84 Med: 17.82 Max: 58.1
Current: 58.1
During the past 13 years, Great Tree Pharmacy Co's highest Yield on Cost was 58.10. The lowest was 2.84. And the median was 17.82.
ROCO:6469's 5-Year Yield-on-Cost % is ranked better than 98.91% of 275
companies
in the Healthcare Providers & Services industry
Industry Median: 2.9
vs ROCO:6469: 58.10
Great Tree Pharmacy Co (ROCO:6469) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Great Tree Pharmacy Co 5-Year Yield-on-Cost % Related Terms
Great Tree Pharmacy Co 5-Year Yield-on-Cost % Competitor Comparison
For the Pharmaceutical Retailers subindustry, Great Tree Pharmacy Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Great Tree Pharmacy Co 5-Year Yield-on-Cost % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Great Tree Pharmacy Co's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Great Tree Pharmacy Co's 5-Year Yield-on-Cost % falls into.
Great Tree Pharmacy Co 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Great Tree Pharmacy Co (ROCO:6469) has a 5-Year Yield-on-Cost % of 58.10 as of Aug. 10, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Great Tree Pharmacy Co and its competitors. This is 226% above median its historical median of 17.82. Over the past decade, Great Tree Pharmacy Co's 5-Year Yield-on-Cost % has ranged from 2.84 to 58.10. According to the industry distribution chart, Great Tree Pharmacy Co ranks #3 out of 275 companies in the Healthcare Providers & Services industry, placing it in the top 1.1%.
Is Great Tree Pharmacy Co's 5-Year Yield-on-Cost % too high?
Great Tree Pharmacy Co's current 5-Year Yield-on-Cost % of 58.10 is 226% above median its 10-year median of 17.82. Over the past 10 years, this metric has ranged from a low of 2.84 to a high of 58.10. The Healthcare Providers & Services industry median 5-Year Yield-on-Cost % is 2.90. Great Tree Pharmacy Co's value of 58.10 is 1903.4% above this industry median. Based on the distribution chart, Great Tree Pharmacy Co ranks #3 out of 275 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Great Tree Pharmacy Co has a GF Score™ of 69/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Great Tree Pharmacy Co's 5-Year Yield-on-Cost % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Great Tree Pharmacy Co ranks #3 out of 275 companies for 5-Year Yield-on-Cost %. This places Great Tree Pharmacy Co in the top 1% of its industry — outperforming the majority of peers. The industry median 5-Year Yield-on-Cost % is 2.90. Great Tree Pharmacy Co's value of 58.10 is 1903.4% above this benchmark. Historically, Great Tree Pharmacy Co's own 5-Year Yield-on-Cost % has ranged from 2.84 to 58.10 over the past decade. While the company's 10-year median is 17.82 vs. the industry median of 2.90, Great Tree Pharmacy Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Healthcare Providers & Services company?
The median 5-Year Yield-on-Cost % among Healthcare Providers & Services companies is 2.90, based on 275 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Great Tree Pharmacy Co's current 5-Year Yield-on-Cost % of 58.10 is 1903.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Great Tree Pharmacy Co and its competitors. For the Healthcare Providers & Services industry, the median 5-Year Yield-on-Cost % is 2.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Great Tree Pharmacy Co's current 5-Year Yield-on-Cost % is 58.10, which is 226% above median its own 10-year median of 17.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Great Tree Pharmacy Co stock overvalued right now?
Based on GuruFocus' analysis, Great Tree Pharmacy Co (ROCO:6469) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$168.07, compared to a current price of NT$70.70 — trading 57.9% below its estimated fair value. The current 5-Year Yield-on-Cost % is 58.10, which is 226% above median its 10-year median of 17.82 and 1903.4% above the Healthcare Providers & Services industry median of 2.90. Great Tree Pharmacy Co's overall GF Score™ is 69/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Great Tree Pharmacy Co (ROCO:6469), the current 5-Year Yield-on-Cost % is 58.10 as of Aug. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Great Tree Pharmacy Co (ROCO:6469) Overvalued in 2026?
Based on GuruFocus' analysis, Great Tree Pharmacy Co stock appears to be undervalued.
The current stock price of NT$70.70 is trading 57.9% below its estimated GF Value™ of NT$168.07.
GuruFocus considers Great Tree Pharmacy Co to be Significantly Undervalued.
Key valuation signals for ROCO:6469:
5-Year Yield-on-Cost %: 58.10 (226% above median its 10-year median of 17.82)
GF Value™: NT$168.07 vs. price of NT$70.70 (57.9% below fair value)
Industry Position: 1903.4% above the Healthcare Providers & Services median (#3 of 275)
No single metric tells the full story. See the ROCO:6469 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Great Tree Pharmacy Co Ltd engages in management and trading of various drugs, health supplements, maternity and infant products, and cosmetics products. It also provides coordinated medicine procurement services to various clinics, outpatient centers, and medical communities. Besides, it is also an agency for domestic and foreign health care products sold in clinics, outpatient centers, and medical communities. Its products include infant formula, baby diapers, Maternal and Infant Related, Adult drinks, Nutrition and health care, Body care, Daily Necessities, medical equipment, and Pet products.
69GF Score
Get the complete analysis for ROCO:6469
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6469 has been successfully added to your 
